Showing results (2651-2660 of 2,696) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|March 12, 2026
Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort studyLalita Priyamvada, Faisal S Minhaj, Toutou Likafi, et al.
The Lancet. Infectious Diseases|February 19, 2026
Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trialM Jahangir Hossain, Fatou Secka, Lady C Sanyang, et al.
The Lancet. Infectious Diseases|February 20, 2026
Development and validation of the AURIS score for predicting candidaemia in Candidozyma auris-colonised patients in the intensive care unit: a bicentric retrospective cohort studyVictor Garcia-Bustos, Francesc Puchades, Fernando Alonso-Ecenarro, et al.
The Lancet. Infectious Diseases|February 9, 2024
Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort studyReena H Doshi, Patrick K Mukadi, Rebecca M Casey, et al.
The Lancet. Infectious Diseases|February 4, 2024
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance studyMarta Bertran, Joshua C D'Aeth, Fariyo Abdullahi, et al.
The Lancet. Infectious Diseases|March 29, 2024
Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trialYnke Larivière, Trésor Zola Matuvanga, Bernard Isekah Osang'ir, et al.
The Lancet. Infectious Diseases|March 22, 2024
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet. Infectious Diseases|March 29, 2024
The emergence of artemisinin partial resistance in Africa: how do we respond?Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, et al.
The Lancet. Infectious Diseases|February 12, 2024
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASMChristina C Chang, Thomas S Harrison, Tihana A Bicanic, et al.
The Lancet. Infectious Diseases|February 24, 2024
Effectiveness of pyriproxyfen-pyrethroid and chlorfenapyr-pyrethroid long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs for malaria control in the third year post-distribution: a secondary analysis of a cluster-randomised controlled trial in BeninManfred Accrombessi, Jackie Cook, Edouard Dangbenon, et al.
Pageof 270